Compare HDB & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HDB | MDT |
|---|---|---|
| Founded | 1994 | 1949 |
| Country | India | Ireland |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.3B | 131.9B |
| IPO Year | 2002 | 2014 |
| Metric | HDB | MDT |
|---|---|---|
| Price | $24.96 | $78.69 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 21 |
| Target Price | N/A | ★ $108.21 |
| AVG Volume (30 Days) | 7.0M | ★ 8.0M |
| Earning Date | 04-18-2026 | 06-03-2026 |
| Dividend Yield | 1.53% | ★ 3.58% |
| EPS Growth | N/A | ★ 30.80 |
| EPS | N/A | ★ 2.76 |
| Revenue | N/A | ★ $33,537,000,000.00 |
| Revenue This Year | N/A | $8.91 |
| Revenue Next Year | $14.82 | $6.54 |
| P/E Ratio | ★ $18.92 | $29.15 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $23.91 | $78.91 |
| 52 Week High | $79.62 | $106.33 |
| Indicator | HDB | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 36.90 | 29.18 |
| Support Level | $23.91 | N/A |
| Resistance Level | $27.79 | $89.01 |
| Average True Range (ATR) | 0.41 | 1.80 |
| MACD | -0.02 | -0.36 |
| Stochastic Oscillator | 3.49 | 0.65 |
HDFC Bank Ltd is an Indian bank. It operates in the following segments: Treasury, Retail banking, Wholesale banking, and Other banking business. The maximum revenue for the company is generated from its Retail banking segment, which serves retail customers through its branch network and other channels. This segment raises customer deposits and provides loans and other services to customers using different product groups. Its other operations include providing wholesale banking services to corporates, government entities, and other enterprises, generating income from its treasury operations, and performing para-banking activities such as offering credit cards, debit cards, etc. Geographically, the company generates a majority of its revenue from its operations in India.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.